| 刘成成,黄慧瑶,石菊芳.我国1996~2015年结直肠癌经济负担的系统评价[J].中国肿瘤,2017,26(11):859-867. |
| 我国1996~2015年结直肠癌经济负担的系统评价 |
| Economic Burden of Colorectal Cancer in China from 1996 to 2015：A Systematic Review |
| 投稿时间：2017-03-07 |
| DOI：10.11735/j.issn.1004-0242.2017.11.A005 |
|
 |
| 中文关键词: 结直肠癌 经济负担 系统评价 中国 |
| 英文关键词:colorectal cancer economic burden systematic review China |
| 基金项目:北京希望马拉松专项基金（LC2012YF44）；国家自然科学基金（81402740）；教育部高等学校博士学科点专项科研基金（20131106120014）；国家重大公共卫生服务项目—城市癌症早诊早治项目；公益性行业科研专项（201402003） |
|
| 摘要点击次数: 3147 |
| 全文下载次数: 682 |
| 中文摘要: |
| 摘 要：［目的］ 了解我国结直肠癌经济负担研究状况。［方法］ 检索Pubmed、中国知网和万方数据库，摘录汇总1996~2015年结直肠癌经济负担研究相关文献的基本信息、方法与结果，费用数据均贴现至2013年值。［结果］ 纳入文献24篇（近5年13篇），人群研究仅1篇，其中23篇个体研究指标多为单一直接医疗费用。例均、次均和日均直接医疗费用中位数（范围）分别是27 962（9428~83 320）元、21 959（15 263~51 971）元和882（527~1310）元，年均增长率分别是6.9%、3.7%和7.8%。例均费用中，东、中、西部地区依次降低，直肠癌高于结肠癌。［结论］ 我国结直肠癌经济负担研究数量增长较快但人群层面数据匮乏；直接医疗费用呈缓慢增长，其中例均直接医疗费用存在大幅低估，且费用可能存在地区和癌变部位差异。 |
| 英文摘要: |
| Abstract：［Purpose］ To synthesize available evidence on economic burden of colorectal cancer (CRC) in China. ［Methods］ Based on Pubmed，CNKI and Wanfang database，literatures about economic burden of CRC in China from January 1996 to December 2015 were searched. Basic information，methods and results of economic burden were extracted and analyzed systematically. Expenditure data were converted to 2013-value Chinese Yuan(CNY) using China’s health care consumer price index.［Results］ A total of 24 literatures were included，covering 12 provinces，of which 13 literatures were published over the past 5 years and only 1 literature was population-level study. Most of the 23 individual-level studies only reported the direct medical expenditure，including medical expenditure per patient，per clinical visit and per day. Median medical expenditure per patient，per clinical visit and per day were 27 962 CNY(range：9428~83 320)，21 959 CNY(15 263~51 971) and 882 CNY(527~1310)，respectively. In addition，annual growth rate for medical expenditure per patient，per clinical visit and per day were 6.9%，3.7% and 7.8%，respectively. The expenditure per patient was on decrease among eastern，central and western region，with the lowest expenditure in western region. Compared with colon cancer，expenditure per patient of rectal cancer was higher. ［Conclusion］ In China，evidence on economic burden of CRC is increasing over past the two decades but the studies are still limited，especially for studies at the population-level. Although the direct medical expenditure of CRC has increased slowly，the medical expenditure per patient in China is more likely underestimated. Expenditure may vary among regions and cancer sites. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |